| Literature DB >> 35419133 |
Hernan Nicolas Lemus1, Miryam Alkayyali1, Eonjung Kim1, Charlotte Cunnigham-Rundles2, Dewitt Pyburn1, Rory Abrams3.
Abstract
The role of the adaptive immune system in mediating COVID-19 is largely unknown. Therefore, it is difficult to predict the clinical course in patients with common variable immunodeficiency (CVID), a disease characterized by dysfunctional lymphocytes and impaired antibody production. We report a case of SARS-CoV-2 infection presenting as isolated neurological symptoms in a patient with CVID. The patient subsequently improved following steroids, intravenous immunoglobulin, and convalescent plasma (CP). The latter has been shown to be safe and efficacious in treating COVID-19 in patients with primary immunodeficiency. Recent data suggest that the mechanism of CNS injury in COVID-19 may be due to immunological dysregulation rather than direct viral-mediated injury. This case exemplifies the complex interaction between the brain, the immune system, and the SARS-CoV-2 virus.Entities:
Keywords: COVID-19; cerebellar; coronavirus; immunocompromised; radiculopathy
Year: 2021 PMID: 35419133 PMCID: PMC8995593 DOI: 10.1177/19418744211050215
Source DB: PubMed Journal: Neurohospitalist ISSN: 1941-8744